लोड हो रहा है...

Reflections on the Importance of Cost of Illness Analysis in Rare Diseases: A Proposal

In the field of rare diseases (RDs), the evidence standard is often lower than that required by health technology assessment (HTA) and payer authorities. In this commentary, we propose that appropriate economic evaluation for rare disease treatments should be initially informed by cost-of-illness (C...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
में प्रकाशित:Int J Environ Res Public Health
मुख्य लेखकों: Armeni, Patrizio, Cavazza, Marianna, Xoxi, Entela, Taruscio, Domenica, Kodra, Yllka
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: MDPI 2021
विषय:
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC7908548/
https://ncbi.nlm.nih.gov/pubmed/33530652
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijerph18031101
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!